• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Turnstone Biologics Corp. - Common Stock (NQ: TSBX )

    2.290 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.290
    Bid (Size) 2.290 (2)
    Ask (Size) 2.560 (2)
    Prev. Close 2.290
    Today's Range 2.290 - 2.290
    52wk Range 1.625 - 13.20
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -11.58%
    -11.58%
    1 Month
    -15.50%
    -15.50%
    3 Month
    -34.94%
    -34.94%
    6 Month
    -0.43%
    -0.43%
    1 Year
    -79.18%
    -79.18%

    More News

    Read More
    TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
    Via InvestorPlace
    Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Appoints William Waddill to its Board of Directors
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
    Via InvestorPlace
    Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Turnstone Biologics to Participate in Upcoming Investor Conferences
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.